Clinical Trial

A Clinical Trial Evaluating the Efficacy, Safety, and Pharmacokinetic Profile of TRD303 for Postoperative Analgesia After Abdominal Surgery in China.

Completed Phase 3
View on ClinicalTrials.gov →
Summary
A multicenter, randomized, double-blind, placebo-positive, parallel-controlled, phase Ⅲ clinical trial of the efficacy, safety and pharmacokinetics of TRD303 solution for postoperative analgesia in patients undergoing abdominal surgery was conducted. The primary objective was to evaluate the efficacy of TRD303 solution for postoperative analgesia after abdominal surgery. The secondary objective was to evaluate the safety and pharmacokinetic profile of TRD303 solution for postoperative analgesia after abdominal surgery.
Protocol Amendment History 3 changes
critical Trial completed 2026-07-21
notable Primary completion pushed: 2026-03-18 -> 2026-04-21 2026-07-21
minor Completion moved earlier: 2026-12-30 -> 2026-06-15 2026-07-21
Trial Details
NCT Number NCT07353307
Lead Sponsor The Third Xiangya Hospital of Central South University
Conditions Pain After Abdominal Surgery
Enrollment 333 participants
Start Date 2025-12-30
Primary Completion 2026-04-21 (estimated)
Study Completion 2026-06-15 (estimated)
Updated on ClinicalTrials.gov 2026-07-20